Browse Studies — Arctuva

Observational

Multicenter Prospective Randomized Study of MaioRegenTM Prime vs. Debridement (Surgical Standard of Care (SSOC)) for the Treatment of Osteochondral Lesion of the Knee Joint - OSTEOCONFIRM Study

The present study aims to compare the efficacy and the safety of MaioRegen Prime to Debridement (SSOC) in patients with deep osteochondral lesions of the knee …

Osteochondral Lesions of the Knee JointOsteochondritis Dissecans (OCD)Early Osteoarthritis

Estimated

~$10 – $1,125

Actual pay is set by the research site.